Revolution Medicines (RVMD) Cash from Operations (2019 - 2026)

Revolution Medicines' Cash from Operations history runs 8 years deep, the most recent figure standing at 354165000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 82.15% year-over-year to 354165000.0; the TTM figure through Mar 2026 stood at 1057471000.0 (down 78.83% YoY), while the FY2025 annual figure was 897741000.0, down 61.05% from the prior year.
• Cash from Operations was 354165000.0 for Q1 2026 at Revolution Medicines, down from 274238000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 51737000.0 in Q3 2022 to a low of 354165000.0 in Q1 2026.
• Historically, Cash from Operations has averaged 140253823.53 across 5 years, with a median of 128167000.0 in 2024.
• The sharpest annual moves came in 2023 and 2024: Cash from Operations fell 13.11% in 2023, then slumped 157.34% in 2024.
• A 5-year view of Cash from Operations shows it stood at 61788000.0 in 2022, then tumbled by 95.12% to 120563000.0 in 2023, then declined by 14.7% to 138290000.0 in 2024, then plunged by 98.31% to 274238000.0 in 2025, then declined by 29.15% to 354165000.0 in 2026.
• The last three Cash from Operations figures came in at 354165000.0 (Q1 2026), 274238000.0 (Q4 2025), and 207311000.0 (Q3 2025), per Business Quant data.